Risk Factors

Consumer Group Said Price of Fat Substitute Could Be Cancer

Published in Cancer Weekly, June 22nd, 1998

A consumer group that has been campaigning against olestra, the new fat substitute, renewed its assault, saying long-term use of the product may cause thousands of cancer cases.

The Center for Science in the Public Interest (CSPI) also said the product - sold under the brand-name Olean by Procter & Gamble - causes far more cases of severe digestive upset than the company will admit to.

The CSPI urged the U.S. Food and Drug Administration (FDA) to either withdraw approval of olestra, or to require more prominent and strongly worded labels about its possible effects.

The product, approved in January 1996, is used in some of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-06-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry